Matches in Wikidata for { <http://www.wikidata.org/entity/Q98385506> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q98385506 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 1ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q98385506 description "article scientifique publié en 2020" @default.
- Q98385506 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q98385506 description "scientific article published on 01 December 2020" @default.
- Q98385506 description "wetenschappelijk artikel" @default.
- Q98385506 description "наукова стаття, опублікована в грудні 2020" @default.
- Q98385506 name "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 name "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 name "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 type Item @default.
- Q98385506 label "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 label "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 label "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 prefLabel "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 prefLabel "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 prefLabel "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 P1433 Q98385506-5AE3C3F8-7BB9-426A-A954-AA9F041AE956 @default.
- Q98385506 P1476 Q98385506-A6E3209E-E194-483D-8C3B-0948349A4172 @default.
- Q98385506 P2093 Q98385506-1BD48663-3F71-4B54-8C38-7EA907192BCB @default.
- Q98385506 P2093 Q98385506-671A0A31-C118-4E3D-BDFD-F17AF0F3F8AF @default.
- Q98385506 P2093 Q98385506-8414FC59-DE83-4CDE-A179-41B2998E89F8 @default.
- Q98385506 P2093 Q98385506-9776B894-A3ED-4692-AE41-739B3075FBF3 @default.
- Q98385506 P2093 Q98385506-D56BB36B-AC93-4E57-9E24-AEEBBA2E19F0 @default.
- Q98385506 P2093 Q98385506-D8548F0F-F8F6-43F9-A71E-9162E55EFBBA @default.
- Q98385506 P2093 Q98385506-F130E8C0-B205-497D-9703-66BBB386BB4B @default.
- Q98385506 P275 Q98385506-E1F26ABB-724D-419F-A146-B02BEF39F6FF @default.
- Q98385506 P304 Q98385506-1A6737C5-6B28-4214-BD6F-32FE6ADB00AA @default.
- Q98385506 P31 Q98385506-11DBACC4-17BD-4041-B951-745B06263781 @default.
- Q98385506 P356 Q98385506-EB321119-A61D-479B-80FA-706ED6610DB2 @default.
- Q98385506 P433 Q98385506-A4F9FE6B-FE7D-44C5-A4AE-2B2AB201BCC0 @default.
- Q98385506 P478 Q98385506-AAB2ED93-CB07-4665-8156-1EF1A1B9236A @default.
- Q98385506 P577 Q98385506-2DA53152-001B-4BDF-A58C-3524BCFF3D2D @default.
- Q98385506 P6216 Q98385506-6C24007F-B799-49AB-9F8C-A287D79A6856 @default.
- Q98385506 P698 Q98385506-6FF9B3A7-2CB0-4859-B545-D09B14AFFB05 @default.
- Q98385506 P932 Q98385506-0FE93BE5-BEFB-4609-8852-7E75DCABDF9D @default.
- Q98385506 P356 14756366.2020.1806259 @default.
- Q98385506 P698 32781872 @default.
- Q98385506 P1433 Q15708877 @default.
- Q98385506 P1476 "Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights" @default.
- Q98385506 P2093 "Ahmed Sabt" @default.
- Q98385506 P2093 "Hatem A Abdel-Aziz" @default.
- Q98385506 P2093 "Howayda Suliman" @default.
- Q98385506 P2093 "Mahmoud M Elaasser" @default.
- Q98385506 P2093 "Ohoud J Alotaibi" @default.
- Q98385506 P2093 "Tarfah Al-Warhi" @default.
- Q98385506 P2093 "Wagdy M Eldehna" @default.
- Q98385506 P275 Q20007257 @default.
- Q98385506 P304 "1616-1630" @default.
- Q98385506 P31 Q13442814 @default.
- Q98385506 P356 "10.1080/14756366.2020.1806259" @default.
- Q98385506 P433 "1" @default.
- Q98385506 P478 "35" @default.
- Q98385506 P577 "2020-12-01T00:00:00Z" @default.
- Q98385506 P6216 Q50423863 @default.
- Q98385506 P698 "32781872" @default.
- Q98385506 P932 "7470104" @default.